Mainat Spends €200k on Hormones to Rejuvenate at 79
Josep Maria Mainat, former member of La Trinca and one of Spain's most influential TV producers, has surprised observers with a visibly rejuvenated appearance at age 79. The Catalan producer undergoes hormonal treatment involving testosterone and human growth hormone injections, reportedly costing over €200,000. He likens the process to "tuning a large orchestra," where each hormone acts as a key instrument to restore balance. His stated goal: living to 120 while looking young.
The case has sparked an uncomfortable debate. On one hand, anti-aging medicine warns these therapies "can help, but only when indicated, under medical supervision, and with strict control." On the other, some hormone therapy specialists advocate their use for age-related symptoms like muscle loss, mood changes, or sleep issues. Price ranges complicate the discussion: growth hormone can exceed €3,000 per month.
What the Treatment Includes and Its Cost
The package extends beyond hormones. Mainat also renewed his dentition and underwent hair transplant surgery, two procedures valued at approximately €5,000 each. Combined with hormonal therapy, the total bill exceeds €200,000—a sum unattainable for most, but trivial for someone who sold his production company and retained a well-paid executive role.
Growth hormone pricing is the most unsettling data point. Over €3,000 monthly, indefinitely. This is not a one-time whim but a recurring expense that only makes sense if maintained long-term. Here lies the medical problem.
Risks Highlighted by Doctors
Exogenous testosterone has side effects rarely antiestéticatured in lifestyle magazines: when blood hormone levels are sufficient, testicles cease production. Prolonged treatment causes production function atrophy, potentially reducing testicular size by 20% to 30%. Interrupting supply turns patients into chemical eunuchs until the hormonal axis reactivates—a process taking considerable time that rarely restores previous levels.
Some argue that after certain ages—50 or 60—hormone replacement becomes permanent. Clomiphene attempts to reactivate endogenous production without guarantees. Natural alternatives—diet, gym, abdominal fat loss—work but offer less dramatic results. A cited example: someone losing four kilos of belly fat via keto diet and exercise improved libido and endurance without medication.
The Longevity Business
Anti-aging medicine generates increasing revenue. Specialized clinics target wealthy older men seeking treatments public healthcare doesn't cover, sometimes bordering on illegality. Specialists warn clearly: without medical indication and strict control, these therapies are dangerous. With supervision, they may improve quality of life. The line between safety and risk is thinner than it appears.
Mainat's case isn't isolated. Global entrepreneurs and celebrities treat longevity as personal projects. Amazon's founder exemplifies this; his recent physical transformation is partly attributed to testosterone. Unlike others who deny or conceal such treatments, Mainat discusses them openly on radio.
La Trinca, Gestmusic, and Endless Wealth
To understand why €200,000 doesn't worry him, consider his wealth source. Mainat wasn't just La Trinca's blonde member. He owned Gestmusic, producer behind formats like Operación Triunfo, Crónicas marcianas, Mira quién baila, and La parodia nacional. Upon selling the company, he kept a lucrative executive position. Married to Rosa María Sardá from a wealthy family, his assets, as one comment noted, "bury us all in money."
With this foundation, spending €200,000 on hormones is economically rational. If successful, he gains quality years; if not, he loses negligible amounts relative to his net worth. The asymmetry is complete.
Debate on Spending and Vanity
Public opinion divides between those advocating financial freedom—legal spending harming no third parties—and critics viewing such expenditure at 79 as vanity or age denial. Comparisons to Amancio Ortega emerge: Inditex's founder faces criticism despite donating millions to cancer research, while Mainat receives applause for cosmetic enhancements. The underlying issue remains: Mainat has money and desires to live to 120. If treatment works, he wins; if it fails, he loses little. Currently, he claims feeling "better than ever." Time will tell if this persists.
Summary of a discussion on Burbuja.info - Foro de economía, actualidad y política., translated from Spanish and reviewed before publication.
Read the full discussion (114 replies).